Literature DB >> 1457041

Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line.

A Bernards1, V H Haase, A E Murthy, A Menon, G E Hannigan, J F Gusella.   

Abstract

Neurofibromatosis type 1 (NF1) is caused by mutations in a large gene on chromosome 17q11.2. Previously described partial cDNAs for this gene predicted a protein related to yeast IRA1/IRA2 and the mammalian RAS GTPase activator protein GAP. To initiate a detailed study of the role of this gene in NF1, we have characterized a set of overlapping cDNAs that represent its complete coding sequence. Our results show that two differentially expressed human NF1 mRNAs differ by a 63-bp insertion in the GAP-related domain. These mRNAs predict two 2,818- and 2,839-amino acid proteins with calculated molecular masses of approximately 317 and 319 kD. Extensive similarity to IRA proteins is evident in a 1,450-amino-acid central segment, roughly between amino acids 900 and 2,350. However, the remainder of the NF1 protein is not significantly similar to other proteins. Interestingly, the SK-N-SH human neuroblastoma line expresses no detectable NF1 mRNA, indicating that expression of NF1 is not essential for viability of this neural crest-derived tumor cell line.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457041     DOI: 10.1089/dna.1992.11.727

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  7 in total

1.  NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.

Authors:  T Cacev; S Radosević; R Spaventi; K Pavelić; S Kapitanović
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

2.  Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons.

Authors:  Melissa N Hinman; Alok Sharma; Guangbin Luo; Hua Lou
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

3.  Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes.

Authors:  P Poullet; B Lin; K Esson; F Tamanoi
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

4.  Analysis of an alternatively spliced exon of the neurofibromatosis type 1 gene in cultured melanocytes from patients with neurofibromatosis 1.

Authors:  I Eisenbarth; S Hoffmeyer; D Kaufmann; G Assum; W Krone
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Evolutionary expansion of the Ras switch regulatory module in eukaryotes.

Authors:  Diego Díez; Francisca Sánchez-Jiménez; Juan A G Ranea
Journal:  Nucleic Acids Res       Date:  2011-03-29       Impact factor: 16.971

6.  Reduced expression of neurofibromin in human meningiomas.

Authors:  V Sundaram; J H Lee; J A Harwalkar; D J Stein; M Roudebush; D W Stacey; M Golubic
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  The C-terminal domains of human neurofibromin and its budding yeast homologs Ira1 and Ira2 regulate the metaphase to anaphase transition.

Authors:  Guangming Luo; Junwon Kim; Kiwon Song
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.